People

Robert N. Weinreb

Robert N. Weinreb, MD, chairs the Scientific Advisory Board of Amydis. His clinical and scientific work focuses on glaucoma, optic neuropathy, retinal imaging and neuroprotection; he trained at Harvard Medical School and UC San Francisco. Robert N. Weinreb advises Spinogenix on science. His clinical and research work at UC San Diego encompasses ophthalmology, glaucoma, retinal imaging and neuroprotection, alongside existing Amydis and RetiSpec affiliations. Robert N. Weinreb is named a machineMD board member in its current public directory. This matches the UC San Diego ophthalmologist and glaucoma researcher already advising Amydis and Spinogenix; prior portrait and all existing roles preserved. Robert N. Weinreb is a current Iantrek board member and glaucoma clinician/researcher at the Shiley Eye Institute. His prior neurological and ophthalmic scientific affiliations and authentic portrait are preserved.

Roles

RetiSpec

Board Member

Current
Amydis

Chair of Scientific Advisory Board

Current
Spinogenix

Scientific Advisory Board Member

Current
machineMD

Board Member

Current
Iantrek, Inc.

Board Member

Current